Robinul Related Clinical Trials
Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease [Not yet recruiting]
Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation [Recruiting]
Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers [Recruiting]
Intranasal Administration of Neostigmine and Glycopyrrolate for Bowel Evacuation [Recruiting]
Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate [Not yet recruiting]
Efficacy and Safety Study of Oral Glycopyrrolate Liquid to Manage Problem Drooling Associated With Cerebral Palsy or Other Neurologic Conditions in Children [Completed]
Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers [Recruiting]
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G) [Recruiting]
Safety Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Condition [Active, not recruiting]
Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular Blockade [Recruiting]
Efficacy and Safety of Four Doses of Glycopyrronium Bromide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium [Completed]
Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children [Recruiting]
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation [Not yet recruiting]
Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981 AM2) [Not yet recruiting]
Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration [Recruiting]
Safety and Tolerability of 28 Days Treatment With Glycopyrrolate(NVA237) (100 or 200µg Once a Day) in Patients With Moderate to Severe COPD [Completed]
CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity [Not yet recruiting]
A 26-week Treatment Randomized, Double-blind, Double Dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 (Indacaterol / Glycopyrronium Bromide) Compared to Fluticasone/Salmeterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Recruiting]
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. [Recruiting]
Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Effect of Reversing Muscle Relaxation With Sugammadex Compared With Usual Care on Bleeding Risk in Patients on Blood Thinners Undergoing Major Joint Surgery (P07038/MK-8616-059) [Recruiting]
Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block [Recruiting]
QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study [Not yet recruiting]
A Study of the Efficacy and Safety of EP-101 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease [Recruiting]
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease [Recruiting]
Long Term Safety Study of NVA237 vs QAB149 in COPD Patients [Recruiting]
Measurement of Autonomic Cardiovascular Integrity in Persons With SCI [Recruiting]
1-year Study to Assess the Efficacy, Safety and Tolerability of NVA237 in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002 [Recruiting]
Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage [Recruiting]
Comparison of T4/T1 Ratio at Time of Tracheal Extubation Using 4 mg/kg Sugammadex Administered at 1-2 PTCs or Better to 50 µg/kg Neostigmine Administered as Per Standard of Care to Reverse Rocuronium-Induced Neuromuscular Blockade in Adult Subjects Undergoing Elective Open Abdominal Procedure [Recruiting]
Scopolamine to Treat Depression
NVA237 Versus Placebo 12-week Efficacy Study [Recruiting]
Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101) [Recruiting]
Balanced Anesthesia for Intubation of Premature Infants [Recruiting]
|
